Improving Weight Loss in Healthy Adults With Overweight and Obesity: An Artificial Intelligence-assisted Dietary Prediction and Prevention System With Continuous Glucose Monitoring
Overweight , ObesityOverweight or Obese AdultsObesityOverweight and/or Obesity
Investigational drug(s) / intervention(s)
eTRIPFatSecret
eTRIP: Intervention group 1 involves using the eating behaviour trigger-response inhibition program(eTRIP) smartphone application for 10 weeks, where participants will need to take pictures of their food items as part of their food logging and may also engage with app-based activities to build self-regulatory skills in sticking to their weight loss plans. Additionally, participants will also apply a continuous glucose monitoring (CGM) sensor on their arm and taught how to scan the CGM sensor so that they can monitor their glucose levels for the first 10 days.
FatSecret: Intervention group 2 involves using the FatSecret smartphone application for participants to monitor their calorie intake, without any continuous glucose monitoring.
Study summary
This study aims to examine the effectiveness of a novel dietary lapse prediction and prevention self-regulation app called the eating behaviour trigger-response inhibition program (eTRIP), and the addition of continuous glucose monitoring (CGM), on healthy eating and weight loss in people with overweight and obesity.
Eligibility
Sex
ALL
Min age
21 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
1. are 21-65 years old
2. have BMI ≥23 kg/m2
3. can comprehend the English language
4. uses a smartphone that can download apps
5. are willing to perform continuous glucose monitoring (CGM) using the Dexcom continuous glucose monitoring system
6. willing to travel to the National University of Singapore (NUS)
7. able to provide informed consent
Exclusion Criteria:
1. are using/intend to use other apps for weight loss;
2. are pregnant or lactating (as it would affect weight change and caloric needs)
3. are diagnosed severe mental disorders (e.g. major depressive disorder and schizophrenia)
4. are on prescribed meal replacements or pharmacotherapy
5. have serious medical conditions
6. are scheduled for any kind of surgery within the next 6 months
Primary outcome measure(s)
Height — At weeks 0, 10 and 24. Taken using a wall mounted measuring tape.
Weight — At weeks 0, 10 and 24. Taken using InBody 120
Waist Circumference — At weeks 0, 10 and 24. Taken using a measuring tape.
BMI — At weeks 0, 10 and 24. Taken using InBody 120
Self regulation of Eating Behaviour Questionnaire (SREBQ) — At weeks 0, 10 and 24. The Self-Regulation of Eating Behaviour Questionnaire (SREBQ) is a validated self-administered instrument used to assess individuals' self-regulation in relation to eating behavior. It evaluates the extent to which individuals monitor, control, and regulate their eating behaviors in everyday contexts. Higher scores indicate greater self-regulation of eating behavior.
Trial sites (1)
Facility
City
Region
Status
National University of Singapore
Singapore
Singapore
More National University Health System, Singapore trials in Singapore
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.